Evotec SE (EVO) Profit After Tax (2009 - 2025)
Evotec SE (EVO) posted Profit After Tax of -$120.4 million for Q4 2025, down 238848.18% sequentially from -$50371.1 in Q3 2025, and up 42.51% YoY from -$84.5 million in Q4 2024.
Evotec SE (EVO) Profit After Tax (2009 - 2025) Analysis & Trends
Evotec SE has reported Profit After Tax for 9 years, with the latest figure at -$120.4 million in Q4 2025.
- Quarterly Profit After Tax rose 42.51% year-over-year to -$120.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$329.8 million (down 10.09% YoY) and the FY2025 annual result came in at -$120.5 million, up 42.49% from the prior year.
- Profit After Tax fell to -$120.4 million in Q4 2025 per EVO's latest filing, from -$50371.1 in the prior quarter.
- Over five years, Profit After Tax peaked at $246.3 million in Q4 2021 and troughed at -$209.4 million in Q4 2024.
- A 5-year average of -$23.5 million and a median of -$29810.4 in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2021 and 2022: Profit After Tax jumped 9714.16% in 2021, then plunged 229.31% in 2022.
- Over 5 years, Profit After Tax stood at $246.3 million in 2021, then slumped by 172.84% to -$179.4 million in 2022, then surged by 49.7% to -$90.2 million in 2023, then plunged by 132.08% to -$209.4 million in 2024, then surged by 42.51% to -$120.4 million in 2025.
- According to Business Quant data, Profit After Tax over the past three periods registered -$120.4 million, -$50371.1, and -$209.4 million for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -120.36 Mn |
| Sep 30, 2025 | -50,371.08 |
| Dec 31, 2024 | -209.36 Mn |
| Sep 30, 2024 | -43,526.83 |
| Dec 31, 2023 | -90.21 Mn |
| Sep 30, 2023 | 42,406.04 |
| Jun 30, 2023 | -16,256.55 |
| Dec 31, 2022 | -179.36 Mn |
| Sep 30, 2022 | 47,666.17 |
| Jun 30, 2022 | -29,810.36 |
| Mar 31, 2022 | -82,202.26 |
| Dec 31, 2021 | 246.25 Mn |
| Sep 30, 2021 | 158,344.09 |
| Jun 30, 2021 | 72,274.35 |
| Mar 31, 2021 | 63,571.06 |
| Dec 31, 2020 | 7.48 Mn |
| Sep 30, 2020 | -1,646.99 |
| Dec 31, 2019 | 41.30 Mn |
| Sep 30, 2010 | 835.45 |
| Jun 30, 2010 | 1,710.83 |